---
$id: https://graph.org.ai/products/commodity/51282911
$type: Product
source: UNSPSC
code: "51282911"
title: "Danofloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Danofloxacin

**UNSPSC Code**: 51282911
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C19H20FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 24CU1YS91D chemically known as 1-cyclopropyl-6-fluoro-1,4-dihydro-7-((1s,4s)-5-methyl-2,5-diazabicyclo(2.2.1)hept-2-yl)-4-oxo-3-quinolinecarboxylic acid but generally known as danofloxacin, which bears US NIH Compound Identifier 71335. European Medicines Agency schedules Danofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06901MIG. The term DANOFLOXACIN is an International Non-Proprietary Name or INN. Most nations schedule danofloxacin under HS 29335995 and SITC 51576. As of Q4 2014, DANOFLOXACIN remains the US FDA Preferred Term for this commodity. Danofloxacin bears US NLM identifiers UMLS ID C0112317 and NCI Concept Code C72731. SMILES: CN1CC2CC1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F.

